Ghrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus

Journal of Endocrinology

Volumn 205, Issue 3, 2010, Pages 263-270

  Lee, Jiyeon ^a   Lim, Eunjin ^a   Kim, Yumi ^a   Li, Endan ^a   Park, Seungjoon ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLOOXYGENASE 2; DEXTRO LYSINE 3 HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; GHRELIN; GHRELIN RECEPTOR; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; HORMONE RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; KAINIC ACID; MATRIX METALLOPROTEINASE 16; MESSENGER RNA; NEURON SPECIFIC NUCLEAR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; DRUG MECHANISM; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEIZURE;

ANIMALS; APOPTOSIS; ASTROCYTES; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; GHRELIN; HIPPOCAMPUS; INTERLEUKIN-1BETA; KAINIC ACID; MALE; MATRIX METALLOPROTEINASE 3; MICE; MICE, INBRED C57BL; MICROGLIA; NEURONS; SEIZURES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952576252     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-10-0040     Document Type: Article

References (50)

1. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA et al. 2001 Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120 337-345.
2. Ben-Ari Y, Tremblay E & Ottersen OP 1980 Injections of kainic acid into the amygdaloid complex of the rat: an electrographic, clinical and histological study in relation to the pathology of epilepsy. Neuroscience 5 515-528.
3. Chen H, Zhang SM, Hernan MA, Schwarzschild MA, Willett WC, Colditz GA, Speizer FE & Ascherio A 2003 Nonsteroidal anti-inflammatory drugs and the risk of Parkinson's disease. Archives of Neurology 60 1059-1064. (Pubitemid 36975791)
4. Choi DW 1988 Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 623-634.
5. Chung H, Kim E, Lee DH, Seo S, Ju S, Lee D, Kim H & Park S 2007 Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen - glucose deprivation. Endocrinology 148 148-159.
6. Chung H, Seo S, Moon M & Park S 2008 Phosphatidylinositol-3-kinase/ Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen - glucose deprivation-induced apoptosis in primary rat cortical neuronal cells. Journal of Endocrinology 198 511-521.
7. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML et al. 2003 The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37 649-661.
8. Coyle JT 1983 Neurotoxic action of kainic acid. Journal of Neurochemistry 41 1-11.
9. Czapinski P, Blaszczyk B & Czuczwar SJ 2005 Mechanisms of action of antiepileptic drugs. Current Topics in Medicinal Chemistry 5 3-14.
10. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K & Nakazato M 2000 Ghrelin, a novel growth hormone-relasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141 4255-4261.
11. Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K & Nakazato M 2002 The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123 1120-1128.
12. Datta SR, Brunet A & Greenberg ME 1999 Cellular survival: a play in three Akts. Genes and Development 13 2905-2927.
13. DeLegge MH & Smoke A 2008 Neurodegeneration and inflammation. Nutrition in Clinical Practice 23 35-41.
14. Doble A 1999 The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacology & Therapeutics 81 163-221.
15. Eng LF & Ghirnikar RS 1994 GFAP and astrogliosis. Brain Pathology 4 229-237.
16. Frago LM, Paneda C, Dickson SL, Hewson AK, Argente J & Chowen JA 2002 Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology 143 4113-4122.
17. Gonzalez-Scarano F & Baltuch G 1999 Microglia as mediators of inflammatory and degenerative diseases. Annual Review of Neuroscience 22 219-240.
18. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van der Ploeg LH & Howard AD 1997 Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Research. Molecular Brain Research 48 23-29. (Pubitemid 27298124)
19. Hald A & Lotharius J 2005 Oxidative stress and inflammation in Parkinson's disease: is there a causal link? Experimental Neurology 193 279-290.
20. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J et al. 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 974-977. (Pubitemid 26275178)
21. Hwang S, Moon M, Kim S, Hwang L, Ahn KJ & Park S 2009 Neuroprotective effect of ghrelin is associated with decreased expression of prostate apoptosis response-4. Endocrine Journal 56 609-617.
22. Kamegai J, Unterman TG, Frohman LA & Kineman RD 1998 Hypothalamic/ pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid. Endocrinology 139 3554-3560.
23. Kim YS, Kim SS, Cho JJ, Choi DH, Hwang O, Shin DH, Chun HS, Beal MF & Joh TH 2005 Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. Journal of Neuroscience 25 3701-3711.
24. Kim YS, Choi DH, Block ML, Lorenzl S, Yang L, KimYJ, Sugama S, Cho BP, HwangO, Browne SE et al. 2007 A pivotal role of matrix metalloproteinase- 3 activity in dopaminergic neuronal degeneration via microglial activation. FASEB Journal 21 179-187.
25. Kojima M & Kangawa K 2005 Ghrelin: structure and function. Physiological Reviews 85 495-522.
26. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K 1999 Ghrelin is a growth hormone-relesasing acylated peptide from stomach. Nature 402 656-660.
27. Lipton SA & Nicotera P 1998 Calcium, free radicals and excitotoxins in neuronal apoptosis. Cell Calcium 23 165-171.
28. Liu Y, Wang PS, Xie D, Liu K & Chen L 2006 Ghrelin reduces injury of hippocampal neurons in a rat model of cerebral ischemia/reperfusion. Chinese Journal of Physiology 49 244-250.
29. Liu Y, Chen L, Xu X, Vicaut E & Sercombe R 2009 Both ischemic preconditioning and ghrelin administration protect hippocampus from ischemia/reperfusion and upregulate uncoupling protein-2. BMC Physiology 9 17.
30. Miao Y, Xia Q, Hou Z, Zheng Y, Pan H & Zhu S 2007 Ghrelin protects cortical neuron against focal ischemia/reperfusion in rats. Biochemical and Biophysical Research Communications 359 795-800.
31. Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, Kim S, Lee D, Chung H, Oh MS et al. 2009 Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation. Neurotoxicity Research 15 332-347.
32. Obay BD, Tasdemir E, Tumer C, Bilgin HM & Sermet A 2007 Antiepileptic effects of ghrelin on pentylenetetrazole-induced seizures in rats. Peptides 28 1214-1219.
33. Park S, Sohn S & Kineman RD 2004 Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: lessons from the spontaneous dwarf rat. Journal of Endocrinology 180 369-378.
34. Pearson G, Robinson F, Beers GT, Xu BE, Karandikar M, Berman K & Cobb MH 2001 Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews 22 153-183.
35. Peino R, Baldelli R, Rodriguez-Garcia J, Rodriguez-Segade S, Kojima M, Kangawa K, Arvat E, Ghigo E, Dieguez C & Casanueva FF 2000 Ghrelin-induced growth hormone secretion in humans. European Journal of Endocrinology 143 R11-R14. (Pubitemid 32066710)
36. Penkowa M, Florit S, Giralt M, Quintana A, Molinero A, Carrasco J & Hidalgo J 2005 Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. Journal of Neuroscience Research 79 522-534. (Pubitemid 40283352)
37. Salinska E, Danysz W & Lazarewicz JW 2005 The role of excitotoxicity in neurodegeneration. Folia Neuropathologica 43 322-339.
38. Sharma AK, Reams RY, Jordan WH, Miller MA, Thacker HL & Snyder PW 2007 Mesial temporal lobe epilepsy: pathogenesis, induced rodent models and lesions. Toxicologic Pathology 35 984-999.
39. Skaper SD 2007 The brain as a target for inflammatory processes and neuro-protective strategies. Annals of the New York Academy of Sciences 1122 23-34.
40. Smith RG, Cheng K, Schoen WR, Pong SS, Hickey G, Jacks T, Butler B, Chan WWS, Chaung L-YP, Judith F et al. 1993 A nonpeptidyl growth hormone secretagogue. Science 260 1640-1643.
41. Sperk G 1994 Kainic acid seizures in the rat. Progress in Neurobiology 42 1-32.
42. Sperk G, Lassmann H, Baran H, Seitelberger F & Hornykiewicz O 1985 Kainic acid-induced seizures: dose-relationship of behavioural, neuro-chemical and histopathological changes. Brain Research 338 289-295. (Pubitemid 15072882)
43. Stroud LM, O'Brien TJ, Jupp B, Wallengren C & Morris MJ 2005 Neuropeptide Y suppresses absence seizures in a genetic rat model. Brain Research 1033 151-156. (Pubitemid 40193409)
44. Tauck DL & Nadler JV 1985 Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. Journal of Neuroscience 5 1016-1022.
45. Teismann P & Schulz JB 2004 Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell and Tissue Research 318 149-161. (Pubitemid 39362635)
46. Teismann P, Tieu K, Cohen O, Choi DK,Wu DC,Marks D, Vila M, Jackson-Lewis V & Przedborski S 2003 Pathogenic role of glial cells in Parkinson's disease. Movement Disorders 18 121-129. (Pubitemid 36305454)
47. Townsend KP & Pratico D 2005 Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. FASEB Journal 19 1592-1601. (Pubitemid 41429517)
48. Wang Q, Yu S, Simonyi A, Sun GY & Sun AY 2005 Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Molecular Neurobiology 31 3-16. (Pubitemid 41271190)
49. Xu J, Wang S, Lin Y, Cao L, Wang R & Chi Z 2009 Ghrelin protects against cell death of hippocampal neurons in pilocarpine-induced seizures in rats. Neuroscience Letters 453 58-61.
50. Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P & Flavell RA 1997 Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389 865-870.